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Dose compensation based on biological effectiveness due to interruption time for 
photon radiation therapy 
 
Abstract 
Objectives: To evaluate the biological effectiveness of dose associated with interruption 5 
time; and propose the dose compensation method based on biological effectiveness when 
an interruption occurs during photon radiation therapy. 
Methods: The lineal energy distribution for human salivary gland tumor was calculated 
by Monte Carlo simulation using a photon beam. The biological dose (Dbio) was estimated 
using the microdosimetric kinetic model. The dose compensating factor with the physical 10 
dose for the difference of the Dbio with and without interruption (∆) was derived. The 
interruption time (τ) was varied to 0.1, 0.2, 0.3, 0.4, 0.5, 1, 2, 3, 4, 5, 10, 20, 30, 40, 50, 
75, and 120 min. The dose per fraction and dose rate varied from 2 to 8 Gy and 0.1 to 24 
Gy/min, respectively.  
Results: The maximum ∆ with 1 Gy/min occurred when the interruption occurred at 15 
half the dose. The ∆ with 1 Gy/min at half of the dose was over 3% for τ >= 20 min for 
2 Gy, τ = 10 min for 5 Gy, and τ = 10 min for 8 Gy. The maximum difference of the ∆ 




Gy. The dose compensating factor was larger with a high dose per fraction and high-dose 
rate beams. 20 
Conclusion: A loss of biological effectiveness occurs due to interruption. Our proposal 
method could correct for the unexpected decrease of the biological effectiveness caused 
by interruption time. 
 
Advances in knowledge: For photon radiotherapy, the interruption causes the sublethal 25 
damage repair (SLDR). The current study proposed the dose compensation method for 
the decrease of the biological effect by the interruption. 
 






1.   Introduction  
Recent technological advancements in radiation therapy, such as immobilization, the 
use of a linear accelerator, imaging, a treatment planning system, and the ability to 
compensate for respiratory motion could utilize intensity-modulated radiation therapy 35 
(IMRT). IMRT delivers precise radiation doses to a tumor while minimizing the dose to 
the surrounding normal tissue. However, these techniques are complex and could require 
more time to deliver the dose than conventional radiation therapy. IMRT uses several 
beams and segments (apertures) that are shaped using a multileaf collimator. The dose is 
delivered either statically or dynamically through the step-and-shoot mode. For multi-40 
beam radiation therapy, the delivery time will frequently increase proportionally to the 
complexity of the treatment technique. For lung or liver cancer patients, respiratory 
control such as respiratory gating or breath-holding techniques is needed to suppress the 
organ or tumor motion [1-2]. Additionally, linac failure causes unscheduled downtime. In 
some cases, it was necessary to transfer patients to other linacs [3]. Consequently, the 45 
doses were delivered intermittently. IMRT could require up to 15 min and SBRT requires 
30 min or longer [4]. Unscheduled downtime increases the interruption time. These 
interruption periods in treatment significantly increase the possibility of error and 




the radiation dose delivered with interruption is equivalent to that administered without 50 
interruption. 
The effect of the interruption time was studied by Elkind et al. who demonstrated 
that cell killing tends to decrease with increased delivery time. This effect was primarily 
related to sublethal damage repair (SLDR) [5]. Mu et al. investigated the effect of 
interruption time through in vitro experiments. The effect of prolonging the fraction time 55 
that includes the beam-on time and interruption times in treatment is underestimated by 
biological models [6]. 
For the estimation of cell survival and the calculation of the biological equivalent 
dose, the linear–quadratic (LQ) model has been widely used [7, 8]. However, the LQ 
model does not represent the effect of the SLDR by the prolonged delivery time and dose 60 
rate effect explicitly. The microdosimetric-kinetic (MK) model is possible to evaluate the 
surviving fraction in terms of microdosimetry [9, 10]. The MK model expresses the 
difference in radiation energy by taking into account the spatial distribution of the energy 
deposition of radiation [11]. Moreover, the MK model is possible to be incorporated the 
biological effect of the SLDR. Matsuya et al evaluated the survival curve with the 65 
experimental data and the fitted data by the LQ and MK models. The MK model which 




effect of longer periods of dose delivery for carbon-ion radiotherapy using the MK model 
[13]. They demonstrated that the biological effect of a planned dose can decrease by 20% 
or more than the curative dose if the interruption time extends to 30 min or longer. 70 
Although our previous study evaluated the effect of delivery time under a continuous 
photon beam, the effect of the interruption time was not assessed [14]. For photon therapy, 
the decrease in the biological effect associated with the interruption time, i.e., a decrease 
in cell killing could also occur.  
The current study aims to reveal the effect of biological dose difference with and without 75 
interruption by a photon beam. Additionally, two types of dose compensation methods to 




2.   Materials and methods  
2.1.    Survival fraction in the MKM 80 
Hawkins et al proposed the MKM, the surviving fraction of cells can be predicted 
from the dose by a ‘‘domain’’ that the cell nucleus was divided [10]. The specific energy 
which is the dose absorbed by any individual domain is defined as z. The average of z for 
the entire population is defined as D which is the macroscopically measured dose. It is 
assumed that the primary lesions in the domain have two types. Type I is a potentially 85 
lethal lesion, which is assumed to correspond to a clustered DNA damage that induces 
chromosome aberrations and it is difficult to repair. A type II lesion occurred after the 
irradiation of the domains. According to their transformations, the type II lesions are 
classified into four categories: (1) be converted to a lethal unrepairable lesion at a constant 
rate a through first-order process; (2) form a lethal unrepairable lesion through second-90 
order process bd by combining with another type II lesion in the same domain; (3) be 
repaired at constant rate c through first-order process; and (4) persist for a length of time 
tr, after which it becomes lethal and unrepairable. Type I and type II lesions are created 
with a proportional to the z with the kdI and λd, respectively. These are expressed as 
following equations: 95 
𝑑𝑥𝐼𝐼
𝑑𝑡
= 𝑘𝑑𝐼?̇? − (𝑎 + 𝑐)𝑥𝐼𝐼-2𝑏𝑑𝑥𝐼𝐼






= 𝜆𝑑?̇? + 𝑎𝑥𝐼𝐼 + 𝑏𝑑𝑥𝐼𝐼
2,    (2) 
where 𝑥𝐼 and 𝑥𝐼𝐼 are the mean number of type I and type lesions per domain at z. the 
Brenner et al assumed that the potentially lethal lesion repair rate, which was defined as 
(a + c), was equivalent to the primary rate λ which was obtained by the DNA repair 100 
half-time T1/2 [15]. 
a + c=  
𝑙𝑛 2
𝑇1/2
,    (3) 
When a population of cells exposed to D at time t = 0 and a domain absorbs z from this 
irradiation, Eq. (1) becomes 
𝑥𝐼𝐼 = 𝑘𝑑𝐼?̇? − (𝑎 + 𝑐)𝑥𝐼𝐼,    (4) 105 
Inaniwa et al showed that the ?̇? that is the time derivative of z is given stochastically 
[16]. The average of 𝑥𝐼 at t→ ∞ taken over all domains of the irradiated cell population 
including all values of z, 𝑥𝐼, is estimated stochastically, and the probability of having no 
lethal lesion in the domain 𝑠𝑑 over the population that the survival fraction is then 
determined by  110 
𝑙𝑛𝑠𝑑= −𝑥𝐼,     (5) 
Consider a population of cells exposed to macroscopic dose D at time t = 0 and a domain 





−𝑙𝑛𝑆 = (𝛼0 + 𝑧1,𝐷𝛽0)𝐷 + 𝛽0𝐷
2,   (6) 115 
The 𝑧1,𝐷 denotes the dose mean specific energy by single energy deposition 
events. The 𝛼0 is the proportional factor to 𝐷 [Gy
−1] and 𝛽0 is the proportionality 
factor to D2 [Gy−2], which are obtained by the survival fraction in the LQ model. 





,    (7) 120 








,     (9) 
where y is the lineal energy, l is the mean chord length expressed as two-thirds times the 
domain diameter, ε is the energy deposited in a domain. The values of rd and ρ, which are 125 
the radius and of the domain and the density of the domain are 0.23 μm and 1.0 g/cm3, 
respectively. The domain size was assumed to be composed of spherical sites with 
diameters from 1 nm to 1 µm. An analytical function was developed based on this result. 
Okamoto et al obtained the domain size from the slope of the linear function, which was 
used in the current study [18]. The f(y) is the probability density of lineal energy. The 130 
lineal energy is a stochastic quantity. When particles interact, they can release different 




probabilities. The value of the distribution function, F(y), is the probability that the lineal 
energy is equal to or less than y. The probability density f(y) is the derivative of F(y) with 
respect to y. 135 
𝑓(𝑦) =
𝑑𝐹(𝑦)
𝑑𝑦⁄     (10) 
 
The linear energy distribution, f(y), is independent of the absorbed dose or dose rate. The 
dose distribution, d(y), can be determined from the above distribution and is the 
normalized distribution of the product yf(y) which represents the relative contribution of 140 
events with magnitude y to the dose. Let D(y) be the fraction of absorbed dose delivered 
with lineal energy less than or equal to y, then the dose probability density, d(y), is the 
derivative of D(y) with respect to y 
𝑑(𝑦) =
𝑑𝐷(𝑦)
𝑑𝑦⁄     (11) 
 145 
2.2.    Lineal energy distribution in PHITS  
TrueBeam linear accelerators (Varian Medical Systems, Palo Alto, USA) with a 
6-MV x-ray beam was modeled in the Particle and Heavy Ion Transport Code System 
(PHITS). Phase space files located above the secondary jaw for Monte Carlo users were 




which is built on the EGSnrc platform [20]. These phase space files created by BEAMnrc 
were transferred to the PHITS system, which performed dose calculation. The virtual 
homogeneous phantom (20 × 20 × 20 cm3) was created; the beam was used for a 5 × 5 
cm2 field size at SSD = 90 cm using PHITS. For the physical dose calculation, the 
calculation grid size used was 2 mm. The photon and electron cut-off energies were set 155 
to 0.01 MeV and 0.7 MeV, respectively. The number of photon histories was 2.0 × 108 in 
BEAMnrc and 4.0 × 109 in PHITS, respectively. The validation of the Monte Carlo 
calculations was performed in our previous study, where we compared simulation and 
measurement results [21]. The Monte Carlo calculation and the corresponding 
measurement in the chamber matched within 1.0%. Using the T-SED function of PHITS, 160 
the y distribution with a 6-MV x-ray beam was calculated [22].  
 
2.3.    Biological dose with MKM for interruption 
For continuous irradiation without interruption, Inaniwa et al derived the 
survival fraction of cells after the irradiation [13]. 165 
−𝑙𝑛𝑆 = (𝛼0 + 𝑧1,𝐷𝛽0)𝐷 + 𝛽















where the T is the delivery time during irradiation, which is calculated with the dose rate 




     (14) 
The current study simulated the lineal energy distribution and calculate the 𝑦𝐷 with 
PHITS. Thus, the Eq. (6) is converted with Eq. (7) as follows: 
−𝑙𝑛𝑆 = (𝛼0 +
𝑦𝐷
𝜌𝜋𝑟𝑑
𝛽0) 𝐷 + 𝛽
′𝐷2   (15) 
The survival fraction with interruption is calculated stochastically following steps similar 175 
to those described by Inaniwa et al. [16]. It was calculated as: 
𝑙𝑛𝑆 =  −(𝛼0 + 𝑧1,𝐷𝛽0)𝐷1 − (𝛼0 + 𝑧2,𝐷𝛽0)𝐷2 − 𝛽1𝐷1
2 − 𝛽2𝐷2
2 − 𝛽3𝐷1𝐷2  (16) 
where S is the survival fraction that is dependent on the dose. The number of the 
interruptions is one. Conventionally radiotherapy has performed with a total dose of 60–
70 Gy in 2Gy/fr [23]. The hypofraction radiotherapy scheme is also used in clinical [24, 180 
25]. On the other hand, a recent study showed that in addition to the direct cell death, 
indirect cell death through vascular damage occurs when tumors are exposed to high dose 
hypo-fractionated irradiation [26]. From these clinical protocols, the current study used 
the dose per fraction (D) of 2-8 Gy. The D is calculated as: 





The 𝐷1 and 𝐷2 are the physical dose at first and second irradiations. The 𝐷1 and 𝐷2 





× 100    (18) 190 
The IDF was changed from the 10%, 30%, 50%, 70%, and 90%.  
The 𝑧1,𝐷 and 𝑧2,𝐷 are dose mean specific energies absorbed by a domain in a 
single event during the first and second irradiations, respectively. The current study used 
the photon beam which energy loss due to the depth is small. Moreover, the current study 
simulated the virtual phantom and a single field is used. Thus, the 𝑧1,𝐷, and 𝑧2,𝐷 are used 195 
the same value. Moreover, the survival fraction can be converted with Eq. (9) as follows: 
𝑙𝑛𝑆 =  − (𝛼0 +
𝑦𝐷
𝜌𝜋𝑟𝑑
𝛽0) 𝐷1 − (𝛼0 +
𝑦𝐷
𝜌𝜋𝑟𝑑
𝛽0) 𝐷2 − 𝛽1𝐷1
2 − 𝛽2𝐷2
2 − 𝛽3𝐷1𝐷2 (19) 
 
The coefficients 𝛽1, 𝛽2, and 𝛽3 are provided by: 
𝛽1 =  
2𝛽
(𝑎+𝑐)2𝑇1






] (20) 200 
𝛽2 =  
2𝛽
(𝑎+𝑐)2𝑇2











{𝑒−(𝑎+𝑐)(𝜏+𝑇2) + 𝑒−(𝑎+𝑐)𝜏 − 𝑒−(𝑎+𝑐)(𝑇1+𝜏+𝑇2) +
𝑒−(𝑎+𝑐)(2𝑡𝑟−𝜏−𝑇2) − 𝑒−(𝑎+𝑐)(2𝑡𝑟−𝑇1−𝜏−𝑇2) − 𝑒−(𝑎+𝑐)(2𝑡𝑟−𝜏) + 𝑒−(𝑎+𝑐)(2𝑡𝑟−𝜏−𝑇1)},    (22) 












     (24) 
In total body irradiation, the dose rate is a factor that influences biological effects, and it 
is accepted practice to keep the dose rate between 0.05 and 0.10 Gy/min [27]. For a 
flattening filter-free beam, the dose rates of up to 24 Gy/min could be used [28]. From 210 
above, the DR ranged from 0.1 to 24 Gy/min. These equations were defined under the 
condition of 𝜏 < 𝑡𝑟 Here, the 𝑡𝑟 with HSG tumor is used 2.28h, which is referenced 
from a previous study [16]. The 𝜏 was defined as the interruption time. The range of the 
τ was assumed the clinical treatment. Kuterdem et al reported the delivery time and beam-
on time of the dynamic multi-leaf collimation in IMRT and it was an average beam pause 215 
duration in dynamic of 7 seconds [29]. For Volumetric Modulated Arc Therapy (VMAT) 
treatments, mechanical motion time was assumed to be 30 seconds, accounting for the 
collimator rotation between gantry arcs [30]. Moreover, an interruption could occur from 
unscheduled downtime with machine failures. Although the interruption might occur over 
120 min, the lesion becomes the lethal and unrepairable after the 𝑡𝑟. Thus, the current 220 
study assumed that the maximum interruption time is used 120 min which is below the 




10, 20, 30, 40, 50, 75, and 120 min.  












]   (25) 225 




















]   (26) 
𝐷𝑏𝑖𝑜
























𝑤𝑖𝑡ℎ are the biological doses without and with interruption, 
respectively. Table 1 shows the cell parameters of the human salivary gland (HSG) tumor 
cells which referenced from a previous study and the calculated yD values for the 6-MV 
x-ray beam, which was the dose-mean lineal energy [18]. The HSG tumor cell is a 235 
standard reference cell line to compare RBE mutually for proton facilities in Korea, Japan, 
etc. [31]. At cell culture, eagle’s minimum essential medium (M4655, Sigma) 
supplemented with 10% fetal bovine serum and antibiotics (100 U/ml penicillin and 100 




105 cells/flask with 5 ml of the medium, and incubated in a 5% CO2 incubator at 37°C 240 
for 2 days prior to irradiation with 6-MV x-ray photon beam. The depths from the 
phantom surface to cells was 100 mm water equivalent depth. Okamoto et al counted 
colonies consisting of more than 50 cells as the number of viable cells. The calculated yD 
value was agreed with the measurement value in a previous study [18]. 
 245 
Table 1. Calculation parameters [parameters (mean and standard deviation (SD)]. The α0 
is the proportional factor to D [Gy−1], β0 is the proportionality factor to D
2 [Gy−2], yD is 
the dose-mean lineal energy, and T1/2 is the DNA repair half-time. 
 
Parameters Mean  SD 
𝛼0 (𝐺𝑦
−1) 0.175 0.023 
𝛽0 (𝐺𝑦
−2) 0.033 - 
T1/2 (min) 22 - 





2.4.    Biological dose difference for interruption 
From a previous study, the Dbio for interruption was underestimated when 
compared with the Dbio without interruption [16]. Our study assumed that the 
underestimated Dbio should be supplied in addition to the prescribed dose when the 
interruption occurred. Thus, the biological dose difference (∆) was estimated according 255 
to the following definition: the deviation of the Dbio without interruption, and that with 








𝑤𝑖𝑡ℎ      (28) 
 260 
2.5.    Dose compensating factor for the biological dose with interruption 
The biological dose with an interruption can be corrected with the ∆ and the 
biological dose without interruption, as follows; 
𝐷𝑏𝑖𝑜
𝑤/𝑜
= (1 + ∆) × (𝐷1,𝑏𝑖𝑜
𝑤𝑖𝑡ℎ + 𝐷2,𝑏𝑖𝑜
𝑤𝑖𝑡ℎ)   (29) 
where, the 𝐷1,𝑏𝑖𝑜
𝑤𝑖𝑡ℎ 𝑖𝑛𝑡𝑒𝑟𝑟𝑢𝑝𝑡𝑖𝑜𝑛
  and 𝐷2,𝑏𝑖𝑜
𝑤𝑖𝑡ℎ 𝑖𝑛𝑡𝑒𝑟𝑟𝑢𝑝𝑡𝑖𝑜𝑛
  are the biological dose with 265 
interruption at first and second irradiation, respectively. In the photon therapy treatment, 
the prescription has been performed with the physical dose. Thus, the ∆ should be 




suggests the two types of dose compensating methods based on the biological dose 
difference with and without interruption, as shown in Fig. 1. One is that the second-270 
irradiation method in which the compensating is performed for D2 after the first 
irradiation. The other is the additional dose method which the additional dose with the 
corrected the D1 immediately after the first and second irradiation is provided. 
 
 275 
 Fig. 1 Two types of dose compensating methods: One is second-irradiation method that 
the decrease of the biological effectiveness with interruption is corrected with the D2 in 
the second irradiation. The other is the additional-irradiation method that the decrease of 
the biological effectiveness with interruption is compensated with the additional dose. 
 280 
 2.5.1    Dose compensating factor in the second-irradiation method 




be the sum of the biological dose at first-irradiation with interruption and the biological 
compensated dose (𝑐𝐷2,𝑏𝑖𝑜





𝑤𝑖𝑡ℎ    (30) 285 
From the Eq. (29) and (30), the 𝑐𝐷2,𝑏𝑖𝑜
𝑤𝑖𝑡ℎ is derived as: 
 
𝑐𝐷2,𝑏𝑖𝑜
𝑤𝑖𝑡ℎ = ∆ × 𝐷1,𝑏𝑖𝑜
𝑤𝑖𝑡ℎ + 𝐷2,𝑏𝑖𝑜
𝑤𝑖𝑡ℎ × (∆ + 1)   (31) 
 
The 𝑐𝐷2,𝑏𝑖𝑜
𝑤𝑖𝑡ℎ can be converted to the physical dose (𝐷2,𝑝ℎ𝑦
𝑤/𝑜

































  (32) 
The dose compensating factor based on biological effectiveness at second irradiation with 





    (33) 295 
 
2.5.2    Dose compensating factor for the additional dose method 
It was assumed that the additional dose with the corrected the D1 (𝑐𝐷1,𝑏𝑖𝑜
𝑤𝑖𝑡ℎ) was 
provided immediately after the first and second irradiation to be equivalent to the 









𝑤𝑖𝑡ℎ   (34) 
 
The 𝑐𝐷1,𝑏𝑖𝑜
𝑤𝑖𝑡ℎ can be converted to the physical dose (𝐷1,𝑝ℎ𝑦
𝑤/𝑜

































 (35) 305 
The dose compensating factor based on biological effectiveness at additional-irradiation 












3.   Results 
3.1.   Survival fraction with a different fraction of the interrupted dose 
Figure 2 shows the survival fraction as a function of interruption time at the IDF 
of 10% and 50% with 1 Gy/min for the D of 2–8 Gy. The survival fraction increases with 315 
an increase in the interruption time. The survival fraction at the IDF of 50% is larger than 





Fig. 2 Survival fraction vs. interruption time at the IDF of (a) 10% and (b) 50% for the D 
of 2–8 Gy. 
 




Figure 3 shows the ∆ as a function of interruption time with 1 Gy/min for the 
D of 2–8 Gy. For the IDF of 10%–90%, the maximum ∆ occurs when the interruption is 
at an IDF of 50%. The ∆ at the IDF of 10% and 30% are identical to that at the IDF of 
90% and 70%, respectively. The smallest ∆ value occurs when the interruption is at the 
IDF of 10% and 90%. The maximum ∆ is larger with a higher dose. Its largest value is 330 
17.4% at the IDF of 50% for 8 Gy. The minimum interruption time of the ∆ × 100 that 
was over 3% occurs with τ = 20 min for 2 Gy, τ =10 min for 5 Gy, and τ = 10 min for 8 
Gy, respectively. For 2 Gy, the ∆ × 100 is within 10% with an interruption time of 0–
120 min. Moreover, the maximum ∆ for 5–8 Gy is larger with a higher dose, which is 





Fig. 3 ∆ when the interruption occurs at the IDF of 10%–90% for the D of (a) 2 Gy, (b) 
5 Gy, and (c) 8 Gy. 
 340 
3.3.    Biological dose difference with a different dose rate for interruption 
Figure 4 shows the ∆ vs. interruption time at the IDF of 50% with 0.5–24 
Gy/min for the D of 2–8 Gy. The ∆ with low-dose rate is smaller. There is a small 
difference in the ∆ × 100 with 0.5–24 Gy/min within 3% for 2 and 5 Gy. The maximum 







Fig. 4 ∆ vs. interruption time with 0.5–24 Gy/min for the D of (a) 2 Gy, (b) 5 Gy, and 
(c) 8 Gy. 350 
 
3.4.    Dose compensating factor with different fraction of the interrupted dose 




irradiation method with 1 Gy/min for the D of 2–8 Gy. The 𝑓2 and 𝑓𝑎𝑑𝑑  are larger 
with a high-dose rate, which indicates a similar result with the ∆. The higher dose has 355 
higher 𝑓2 and 𝑓𝑎𝑑𝑑 . Its largest values are 1.50 for the 𝑓2 at an IDF of 90% and 0.49 
for the 𝑓𝑎𝑑𝑑  at an IDF of 10% for 8 Gy. The maximum 𝑓2 and 𝑓𝑎𝑑𝑑  are larger with a 




Fig. 5 𝑓2 when the interruption occurs at the IDF of 10%–90% for the D of (a) 2 Gy, 





Fig. 6 𝑓𝑎𝑑𝑑  when the interruption occurs at the IDF of 10%–90% for the D of (a) 2 Gy, 365 
(b) 5 Gy, and (c) 8 Gy. 
 
3.5.    Dose compensating factor with different dose rate for interruption 
Figures 7 and 8 show the 𝑓2  and 𝑓𝑎𝑑𝑑   in second-irradiation method and 
additional-irradiation method at the IDF of 50% with 0.5–24 Gy/min for the D of 2–8 Gy. 370 
The 𝑓2 and 𝑓𝑎𝑑𝑑  are larger with high-dose rate, which indicates a similar result with the 
∆. The higher D has higher 𝑓2 and 𝑓𝑎𝑑𝑑 . Its largest values are 1.43 for the 𝑓2 and 0.43 






Fig. 7 𝑓2 vs. interruption time with 0.5–24 Gy/min for the D of (a) 2 Gy, (b) 5 Gy, and 







Fig. 8 𝑓𝑎𝑑𝑑  vs. interruption time with 0.5–24 Gy/min for the D of (a) 2 Gy, (b) 5 Gy, and 
(c) 8 Gy. 
 
 




4.   Discussion  
  The present study reveals that the biological effect of SLDR due to interruption 
time during photon radiotherapy was significant. The unexpected decrease of the 
biological effectiveness, which was compensated with the physical dose that was defined 
as the dose that should be added after the interruption. A previous study revealed that the 390 
SLDR occurred between interruption times of 2–3 min, or longer [32]. The current study 
showed that the biological dose difference with and without interruption was over 3% at 
the interruption, that is longer than 3 min for all of the D. Benedict et al. estimated the 
biological effectiveness with an interruption for stereotactic radiosurgery in vitro [33]. 
They reported that the effect of radiation decreased by 9–14% at 8 Gy when the treatment 395 
time elongates by 30 min. In the current study, a similar decrease in the biological 
effectiveness occurred. Additionally, the current study showed that the biological dose 
difference depends on the dose per fraction, dose rate, and the dose before and after 
interruption. 
The interruption time of the biological dose difference with and without 400 
interruption at over 3% was 10 min with 8 Gy with 1 Gy/min. For radiation therapy 
techniques, a previous study reported the dose delivery time for bladder cancer with 2 Gy 




4.29 min with IMRT, and 1.14 min with volumetric-modulated arc therapy (VMAT) [34]. 
Thus, the difference of the biological dose with and without interruption was within 3% 405 
with 2 Gy for all of the radiotherapy techniques. Ong et al. reported that the dose delivery 
time was 11.6 min for 3DCRT, 12 min for IMRT, and 3.9 min for VMAT for hypofraction 
radiotherapy [35]. Although the delivery time includes the beam-on time and interruption 
time, the difference of the biological dose with and without interruption for VMAT is 
within 3% even if the delivery time is almost composed of the interruption time. On the 410 
other hand, the biological dose difference with and without interruption is possible to be 
over 3% for 3DCRT and IMRT in hypofraction radiotherapy. Moreover, the interruption 
could occur once if there are issues with the machine, hardware, and patient in clinical 
practice. For the decrease of the biological effectiveness with the interruption by 
complexity irradiation method or machine failures, the current study proposed the dose 415 
compensation model of the second-irradiation method and additional-irradiation method. 
Recently, the treatment technique has been advanced and multiple-direction beam with 
non-uniform beamlets at each segment or doses at each voxel is used in clinical [36]. 
Second-irradiation method was assumed that the dose profile at first irradiation is the 
same with second irradiation. Thus, it may be difficult to apply the second irradiation 420 




prompt irradiation that minimized the treatment interruptions after second irradiation.   
Recently, flattening filter-free beams have been able to provide improved clinical 
throughput since they exhibit a high dose rate compared with the flattening filter (FF) 
beams. Turner et al. demonstrated that the greater impact of higher dose rates has been 425 
confirmed in a study report concerning irradiated mice [37]. Although increasing 
interruption time caused an increase in the delivery time, the effect of the dose rate for 
the difference of the biological dose with and without interruption was larger with a high 
dose per fraction. Therefore, the dose compensating model requires adjustment according 
to the dose rate. 430 
There were limitations in our dose compensating model. Mu et al. reported that 
the prolonged fraction delivery time within the time frame for complex radiotherapy 
techniques, such as IMRT and hypofraction radiotherapy, can decrease the biological 
effectiveness [38]. The biological effect by the accumulation of the small dose with the 
interruption could be insignificant. Our study could not evaluate the ∆  for certain 435 
interruptions; this demands further evaluation and research. Additionally, our simulation 
was performed with only an HSG tumor cell; thus, it is necessary for the ∆ should be 
evaluated with other tumor or normal cells. The current study incorporated the SLDR. 




occurs. The other repair such as potentially lethal damage repair is not considered in the 440 
current study. Moreover, Carlson et al. investigated the correlation of the cell kill and 
regions of hypoxia for conventional fractionation and hypofraction radiotherapy [37]. The 
other factors of the biological effects, such as tumor hypoxia and tumor repopulation, are 
beyond the scope of this study. Although the current study evaluated the biological 
effectiveness due to the SLDR by the interruption in a simulation study, portions of it are 445 
in agreement with previous experimental studies. For clinical purposes, the biological 
effectiveness due to interruption is difficult because existing treatment planning systems 
could not perform the biological dose calculation using MKM. Our proposed model with 
physical dose can be compensated for the biological dose difference without biological 
dose calculating if the decrease of the biological effect occurs due to interruption. 450 
Although the current study focused on the point prescription method, IMRT uses volume 
prescription that the dose was accumulated at each of voxels [39]. To apply the biological 
dose compensation model in volume prescription, a further study which assesses the 







5.   Conclusions  
The interruption caused the loss of biological effect. The dose compensation model 
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Fig. 1 Two types of dose compensating methods: One is second-irradiation method that 
the decrease of the biological effectiveness with interruption is corrected with the D2 in 
the second irradiation. The other is the additional-irradiation method that the decrease of 
the biological effectiveness with interruption is compensated with the additional dose. 
 590 
Fig. 2 Survival fraction vs. interruption time at the IDF of (a) 10% and (b) 50% for the D 
of 2–8 Gy. 
 
Fig. 3 ∆ when the interruption occurs at the IDF of 10%–90% for the D of (a) 2 Gy, (b) 
5 Gy, and (c) 8 Gy. 595 
 
Fig. 4 ∆ vs. interruption time with 0.5–24 Gy/min for the D of (a) 2 Gy, (b) 5 Gy, and 
(c) 8 Gy. 
 
Fig. 5 𝑓2 when the interruption occurs at the IDF of 10%–90% for the D of (a) 2 Gy, (b) 600 





Fig. 6 𝑓𝑎𝑑𝑑  when the interruption occurs at the IDF of 10%–90% for the D of (a) 2 Gy, 
(b) 5 Gy, and (c) 8 Gy. 
 605 
Fig. 7 𝑓2 vs. interruption time with 0.5–24 Gy/min for the D of (a) 2 Gy, (b) 5 Gy, and 
(c) 8 Gy. 
 
Fig. 8 𝑓𝑎𝑑𝑑  vs. interruption time with 0.5–24 Gy/min for the D of (a) 2 Gy, (b) 5 Gy, and 
(c) 8 Gy. 610 
 
